ZYDUSLIFE - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 4.3
| Stock Code | ZYDUSLIFE | Market Cap | 91,059 Cr. | Current Price | 905 ₹ | High / Low | 1,059 ₹ |
| Stock P/E | 18.9 | Book Value | 215 ₹ | Dividend Yield | 1.22 % | ROCE | 30.6 % |
| ROE | 31.2 % | Face Value | 1.00 ₹ | DMA 50 | 911 ₹ | DMA 200 | 945 ₹ |
| Chg in FII Hold | -0.28 % | Chg in DII Hold | 0.22 % | PAT Qtr | 1,157 Cr. | PAT Prev Qtr | 385 Cr. |
| RSI | 53.8 | MACD | -5.36 | Volume | 5,22,626 | Avg Vol 1Wk | 5,56,706 |
| Low price | 795 ₹ | High price | 1,059 ₹ | PEG Ratio | 0.26 | Debt to equity | 0.35 |
| 52w Index | 41.7 % | Qtr Profit Var | 46.4 % | EPS | 48.0 ₹ | Industry PE | 29.1 |
📈 ZYDUSLIFE demonstrates strong fundamentals with high ROE (31.2%) and ROCE (30.6%), supported by robust quarterly profit growth. The current price (905 ₹) is slightly below both the 50 DMA (911 ₹) and 200 DMA (945 ₹), suggesting near-term weakness but potential for recovery. RSI at 53.8 indicates neutral momentum, while MACD is negative, pointing to short-term consolidation. With a PEG ratio of 0.26 and undervaluation compared to the industry PE (29.1 vs. 18.9), the stock looks attractive for swing trading. Optimal entry would be around 880–890 ₹. If already holding, consider exiting near 1,020–1,040 ₹, close to resistance levels.
🌟 Positive
- Strong quarterly profit growth (PAT rose from 385 Cr. to 1,157 Cr.)
- High efficiency metrics: ROE 31.2% and ROCE 30.6%
- PEG ratio of 0.26 indicates undervaluation relative to growth
- Debt-to-equity ratio at 0.35 shows healthy balance sheet
⚖️ Limitation
- Stock trading below both 50 DMA and 200 DMA, showing short-term weakness
- MACD negative (-5.36), signaling bearish momentum
- FII holding decreased (-0.28%), reflecting reduced foreign investor interest
🚨 Company Negative News
- No major negative news reported, but technical indicators show weakness
✅ Company Positive News
- Quarterly profit variation of 46.4% highlights strong earnings momentum
- Dividend yield of 1.22% adds to investor confidence
🏭 Industry
- Industry PE at 29.1 vs. stock PE of 18.9 shows undervaluation
- Pharmaceutical sector remains resilient with steady demand
📌 Conclusion
ZYDUSLIFE is fundamentally strong and undervalued compared to industry peers. Despite short-term technical weakness, strong earnings growth makes it a good candidate for swing trading. Enter near 880–890 ₹ and exit around 1,020–1,040 ₹ for optimal returns.